Capital structure reset
A 13-for-1 share consolidation took effect in March 2021. Share counts and per-share comparisons require that basis adjustment.
Aura’s financial story is a development-and-funding cycle, not a uranium production history. Exploration assets expanded while operating and investing cash flows remained negative. The latest increase in accounting loss also includes substantial non-cash charges, making it important to read cash, asset carrying values and earnings separately.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Balance-date cash, not committed project funding.
Includes material share-based and impairment charges.
Accounting carrying amount at June 2025.
Cash payments, not total group loss.
Tiris in Mauritania and Häggån in Sweden underpin the development portfolio. The disclosed interests differ: Tiris is 85% owned while Häggån is 100%. Group asset balances cannot be translated directly into wholly owned uranium output.
Studies and engineering advanced the project case, but funding discussions and future production targets are not completed financing or historical sales. This review therefore prioritises cash deployment and the conditions attached to the development timetable.
A 13-for-1 share consolidation took effect in March 2021. Share counts and per-share comparisons require that basis adjustment.
Tiris resource-upgrade work progressed; a Tasiast spin-off was announced in November 2021. Announcement is not treated as a completed disposal.
The enhanced Tiris DFS was released in the March 2023 quarter, followed by engineering work. Study production rates remain forward-looking.
The February 2024 FEED milestone advanced the project definition while exploration cash expenditure increased.
The Curzon fee was settled in shares in August 2024. Tasiast South was fully impaired, while project financing remained a separate requirement.
The latest financing inflow did not fully offset operating and investing outflows. Accounting loss also rose sharply, but it is not a proxy for the amount of cash invested in Tiris.
A$ million
AI-generated presentation · values from Five-year group earnings and cash flows; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Five-year group earnings and cash flows; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Group loss after tax | (2.985) | (3.404) | (6.796) | (6.610) | (15.343) |
| Net operating cash flow | (0.966) | (2.691) | (3.521) | (4.836) | (6.555) |
| Net investing cash flow | (0.608) | (2.729) | (7.262) | (12.068) | (10.456) |
| Net financing cash flow | 4.576 | 12.956 | 11.639 | 22.116 | 12.231 |
| Closing cash - cash-flow statement | 3.207 | 10.707 | 11.276 | 16.471 | 11.741 |
FY2023 group loss uses the restated FY2024 comparative. Cash flows use their identified fiscal years, including the FY2023 original extraction.
Group loss is not the attributable loss or total comprehensive loss. FY2022 cash-flow closing cash includes the reporting perimeter of that statement, not just its separately presented balance-sheet bank line.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration and evaluation assets account for most of the balance sheet. Their growth records capitalised work and project interests, while net current assets captures a narrower liquidity position. Neither metric removes the need to fund future development.
A$ million
AI-generated presentation · values from Exploration assets dominate the balance sheet; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 23.708 | 34.909 | 41.371 | 58.874 | 63.186 |
| Exploration and evaluation assets | 20.397 | 22.323 | 29.946 | 41.895 | 50.549 |
| Total liabilities | 1.708 | 1.294 | 1.569 | 3.806 | 2.358 |
| Total group equity | 22.001 | 33.614 | 39.802 | 55.068 | 60.828 |
| Net current assets | 1.604 | 11.287 | 9.804 | 13.044 | 9.871 |
FY2023 balance-sheet observations are restated comparatives. Group equity includes non-controlling interests.
Capitalised exploration is a carrying amount, not cash, a reserve valuation or proof that construction is financed.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration cash payments rose as studies and engineering progressed, then eased in FY2025. The asset carrying amount can still grow because cash payments, capitalised costs, impairment and currency effects are different accounting movements.
A$ million
AI-generated presentation · values from Cash invested in exploration and evaluation; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Exploration and evaluation cash payments | (0.608) | (2.723) | (7.260) | (11.990) | (10.253) |
Signed cash payments. This row is neither the annual expense in profit or loss nor the closing capitalised asset balance.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The sharp increase in share-based payments and the Tasiast write-down are important when interpreting FY2025 earnings. Curzon received shares for restructuring the uranium offtake agreement; the stated A$5.4m fee should not be described as a cash payment. No unsupported adjusted-profit figure is constructed here.
A$ million
AI-generated presentation · values from Selected expense drivers behind the FY2025 loss; no missing values plotted as zero.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Employee benefits | (2.324) | (2.202) |
| Corporate and administration | (3.533) | (4.766) |
| Share-based payments | (0.585) | (6.278) |
| Impairment | 0.000 | (2.640) |
Selected expenses, not a complete profit reconciliation. Share-based payments and impairment are not additional cash exploration payments.
The company disclosed a A$5.4m Curzon restructuring fee settled in shares and a full A$2.640m write-down of Tasiast South; these are distinct transactions.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The FY2025 report retained material going-concern uncertainty if further funding could not be secured. Its reference to additional funding in Q2 2026 was a forecast at that report date, not confirmation of a subsequent raising.
The issuer also disclosed differing interpretations of the Tiris development deadline. It reported legal advice that permits remained valid, no default notice, and extension discussions. Both the timing issue and the company’s response are preserved here; this is not an independent legal conclusion.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Placement proceeds after issue costs | 16.874 | 13.597 |
| Option funding receipts | 3.691 | 0.000 |
| Option funding repayments | (1.952) | (1.222) |
| Closing short-term loans | 1.202 | 0.000 |
| Current lease liabilities | 0.111 | 0.197 |
| Non-current lease liabilities | 0.151 | 0.085 |
Cash receipts and repayments are annual flows; loan and lease rows are closing balances and must not be added to those flows.
Repayment of short-term borrowing does not remove lease obligations or the need for future project financing.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.